The Asia pacific Metagenomics market is expected to reach US$ 61.9 Mn in 2027 from US$ 30.6 Mn in 2018. The market is estimated to grow with a CAGR of 8.5% from 2018-2027.
The growth of the market is driven by the factors such as increasing demand for genomics, growing demand for metagenomics over traditional methods and various applications of metagenomics, in the Asia pacific region. Whereas, expensive techniques of metagenomics is likely to have a negative impact on the growth of the market in the coming years.
In Asia Pacific, the government is supporting more for the genomics and with the support from the government the Chinese players are investing more into the genetic research. The genomics in this region is booming due to the increasing demand for the genetic sequencing. The rise in the Asia’s genomics market is driven by the factors such as rise in the geriatric population, significant growth of the healthcare system and rise in the income of the population. The Chinese government has made compulsion for the data banking of its citizens, the population’s includes genomic data of the people. In addition, a data provided by the Chinese genetics leader BGI states that in China market size of the genetic testing has grown by five times of a market share which is approximately to US$ 925 billion in between 2012 to 2016. Moreover, near around 330 million people of age of 65years and above are anticipated in 2025, therefore the rise in the personalized medicine is expected to grow the market in coming future. Also, investments in the field of genomics is rising For instance, in 2016, the Chinese Academy of Sciences had launched the initiative for precision medicine. Whereas it invested approximately US$ 9 billion to a project that will sequence over 100 million human genomes by 2030. Recently in December 2017, the China’s Ministry of Science and Technology has joined with a human genome research project to document the genetic makeup of 25,000 people.
Owing to growing demand for genomics by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.
China is anticipated to lead the adoptions of Metagenomics across the Asia Pacific region through the forecast period. The metagenomic market in china is anticipated to witness significant growth in the forecast period owing to the extensive conduction of metagenomics. For instance. a project titled as ‘Metagenomic Analysis of Flaviviridae in Mosquito Viromes Isolated From Yunnan Province in China Reveals Genes From Dengue and Zika Viruses’ was conducted. This project was funded by some Chinese entities which include the National Program on Key Research Project of China, Special Fund for Agro-scientific Research in the Public Interest, National Natural Science Foundation of China and others. This project utilized Illumina sequencing to conclude its results.
Rest of Asia Pacific Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION
By Product
• Instruments & Software
• Consumables
ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION
By Application
• Clinical Diagnostics
• Drug Discovery
By Country
• China
• India
• Japan
Companies Mentioned
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.
• Illumina Inc.
• F Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience of California, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Asia pacific Metagenomics Market – Key takeaways
PART 3. Asia pacific Metagenomics market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Asia pacific Metagenomics Market – By Product
3.2.2 Asia pacific Metagenomics Market – By Application
3.2.3 Asia pacific Metagenomics Market – By Country
3.3 PEST Analysis
3.3.1 Asia pacific – PEST Analysis
PART 4. Asia pacific Metagenomics market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Investments in the field of Metagenomics
4.1.2 Benefits of Metagenomics Over Traditional Methods
4.1.3 Diverse Potential Applications of Metagenomics
4.2 Key Market Restraints
4.2.1 High Cost Associated With Metagenomics
4.3 Key Market Opportunities
4.3.1 Precision Metagenomic Analysis In Personalised Medicine
4.4 Key Market Trends
4.4.1 Growing Trend of Molecular-Based Approaches
4.5 Impact analysis
PART 5. Metagenomics market – Asia pacific Analysis
5.1 Asia pacific Metagenomics market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Illumina, Inc.
Qiagen
5.4 expert opinions
PART 6. Asia pacific Metagenomics market Analysis – By Product
6.1 Overview
6.2 ASIA PACIFIC metagenomics MARKET, BY product, 2018 & 2027 (%)
6.3 Asia pacific Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.4 Instruments & Software Market
6.4.1 Overview
6.4.2 Asia pacific Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Consumables Market
6.5.1 Overview
6.5.2 Asia pacific Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
PART 7. Asia pacific Metagenomics market Analysis – By Application
7.1 Overview
7.2 ASIA PACIFIC Metagenomics MARKET, BY application, 2018 & 2027 (%)
7.3 Clinical Diagnostic Market
7.3.1 Overview
7.3.2 Asia pacific Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Drug Discovery metagenomics Market
7.4.1 Overview
7.4.2 Asia pacific Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Others Market
7.5.1 Overview
7.5.2 Asia pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
PART 8. Asia pacific Metagenomics market Revenue and Forecasts to 2027
8.1 Overview
8.2 Asia pacific metagenomics Market Revenue And Forecasts to 2027, By Country (%)
8.3 US Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.3.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.4 Canada Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.4.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.4.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.5 Mexico Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.5.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.5.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
PART 9. Metagenomics Market –Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Metagenomics Market, 2015-2018
9.3 Organic Developments
9.3.1 Overview
9.4 Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
9.5 Product Launch
9.5.1 Recent Product Launch By Players In The Metagenomics Market
9.6 Product approval
9.6.1 Recent Product Approval By Players In The Metagenomics Market
9.7 Expansion & Others
9.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
9.8 Inorganic developments
9.8.1 Overview
9.9 inOrganic Growth Strategies in the Metagenomics Market, 2015-2018
9.10 Acquisitions
9.10.1 Acquisitions By Players In The Metagenomics Market
9.11 Agreements
9.11.1 The Metagenomics Market By Agreements
9.12 Partnership & Collaboration
9.12.1 Partnership By Players In The Metagenomics Market
PART 10. Metagenomics Market–Key company profiles
10.1 Merck KGaA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Thermo Fisher Scientific, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Agilent Technologies, Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 QIAGEN
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Perkin Elmer, inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Illumina, Inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 F. Hoffmann-La Roche Ltd.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Oxford Nanopore Technologies Ltd.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product & Services Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Pacific Bioscience of California, inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product & Services Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. Asia pacific Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. US Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 3. US Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 4. Canada Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 5. Canada Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 6. Mexico Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 7. Mexico Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 8. Recent Product Launch in the Metagenomics Market
TABLE 9. Recent Product Approval and Enhancements in the Metagenomics Market
TABLE 10. the Metagenomics Market by Exansion & Others Strategies
TABLE 11. Acquisitions in the Metagenomics Market
TABLE 12. the Metagenomics Market by Agreements
TABLE 13. partnership in the Metagenomics Market
TABLE 14. Glossary of Terms, Metagenomics market
LIST OF FIGURES
FIGURE 1. US Metagenomics market, Revenue (US$ Mn), By 2018 & 2027
FIGURE 2. Asia pacific Metagenomics Market By product, Market Share (%), 2018
FIGURE 3. Asia pacific Metagenomics Market By application, Market Share (%), 2018
FIGURE 4. Metagenomics market Segmentation
FIGURE 5. Asia pacific PEST Analysis
FIGURE 6. Metagenomics market impact analysis of drivers & Restraints
FIGURE 7. Asia pacific Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027
FIGURE 8. Asia pacific metagenomics market By Product, 2018 & 2027 (%)
FIGURE 9. Asia pacific Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 10. Asia pacific Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 11. Asia pacific Metagenomics market By application, 2018 & 2027 (%)
FIGURE 12. Asia pacific Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 13. Asia pacific Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 14. Asia pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 15. Asia pacific Metagenomics Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 16. US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. Growth Strategies in the Metagenomics Market, 2015-2018
FIGURE 20. Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
FIGURE 21. Inorganic developments in the Metagenomics Market, 2015-2018
The List of Companies
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Qiagen
- Bio-Rad Laboratories, Inc.
- Perkinelmer Inc.
- Illumina Inc.
- F Hoffman-La Roche Ltd.
- Oxford Nanopore Technologies Ltd.
- Pacific Bioscience of California, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Metagenomics Market
Feb 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Feb 2019